Two Ohio counties and four drug companies agreed to a $260 million settlement, averting the first federal opioid trial an hour before opening arguments were scheduled to begin Monday. The deal is between distributors McKesson, AmeriSourceBergen and Cardinal Health, along with Teva Pharmaceuticals, an Israeli manufacturer, and Ohio’s Summit and Cuyahoga counties. The Washington Post reported that the counties will receive $235 million…